CogstateFRA:C4B +1.82%69 EV-to-FCF is 87.28 as of Jun. 24, 2026, which is 318% above its 10-year median of 20.89. GuruFocus rates FRA:C4B with a GF Score™ of 69/100 and a GF Value™ of €1.35 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 410 Healthcare Providers & Services companies, Cogstate ranks worse than 90.24% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cogstate's Enterprise Value is €257.56 Mil.
Cogstate's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €2.95 Mil. Therefore, Cogstate's EV-to-FCF for today is 87.28.
The historical rank and industry rank for Cogstate's EV-to-FCF or its related term are showing as below:
FRA:C4B'
s EV-to-FCF Range Over the Past 10 Years
Min: -107.49 Med: 20.89 Max: 157.4
Current: 80.09
During the past 13 years, the highest EV-to-FCF of Cogstate was 157.40. The lowest was -107.49. And the median was 20.89.
FRA:C4B's EV-to-FCF is ranked worse than 90.24% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.47
vs FRA:C4B: 80.09
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cogstate's share price for today is €1.68.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cogstate's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.053.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cogstate EV-to-FCF Related Terms
Cogstate EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Cogstate's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Cogstate's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cogstate EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Cogstate's EV-to-FCF falls into.
Cogstate's current Enterprise Value is €257.56 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cogstate's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €2.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cogstate (FRA:C4B) has a EV-to-FCF of 87.28 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cogstate and its competitors. This is 318% above median its historical median of 20.89. According to the industry distribution chart, Cogstate ranks #370 out of 410 companies in the Healthcare Providers & Services industry, placing it in the top 90.2%.
Is Cogstate's EV-to-FCF too high?
Cogstate's current EV-to-FCF of 87.28 is 318% above median its 10-year median of 20.89. The Healthcare Providers & Services industry median EV-to-FCF is 17.47. Cogstate's value of 87.28 is 399.6% above this industry median. Based on the distribution chart, Cogstate ranks #370 out of 410 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cogstate has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cogstate's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cogstate ranks #370 out of 410 companies for EV-to-FCF. This places Cogstate in the lower half of its industry. The industry median EV-to-FCF is 17.47. Cogstate's value of 87.28 is 399.6% above this benchmark. While the company's 10-year median is 20.89 vs. the industry median of 17.47, Cogstate has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.47, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cogstate's current EV-to-FCF of 87.28 is 399.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cogstate and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cogstate's current EV-to-FCF is 87.28, which is 318% above median its own 10-year median of 20.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogstate stock overvalued right now?
Based on GuruFocus' analysis, Cogstate (FRA:C4B) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.35, compared to a current price of €1.68 — trading 24.4% above its estimated fair value. The current EV-to-FCF is 87.28, which is 318% above median its 10-year median of 20.89 and 399.6% above the Healthcare Providers & Services industry median of 17.47. Cogstate's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Cogstate (FRA:C4B), the current EV-to-FCF is 87.28 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cogstate (FRA:C4B) Overvalued in 2026?
Based on GuruFocus' analysis, Cogstate stock appears to be overvalued.
The current stock price of €1.68 is trading 24.4% above its estimated GF Value™ of €1.35.
GuruFocus considers Cogstate to be Modestly Overvalued.
Key valuation signals for FRA:C4B:
EV-to-FCF: 87.28 (318% above median its 10-year median of 20.89)
GF Value™: €1.35 vs. price of €1.68 (24.4% above fair value)
Industry Position: 399.6% above the Healthcare Providers & Services median (#370 of 410)
No single metric tells the full story. See the FRA:C4B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
69GF Score
Get the complete analysis for FRA:C4B
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:C4B has been successfully added to your 
